Cost-effectiveness of linezolid vs. vancomycin in nosocomial pneumonia due to suspected methicillin-resistant Staphylococcus aureus in France

被引：0
|
作者：
De Cock, E. [1 ]
Timsit, J. F. [2 ]
Carlet, J. [3 ]
Leroy, O. [4 ]
Wolff, M. [5 ]
Levrat, F. [6 ]
机构：
[1] United BioSource Corp, Barcelona, Spain
[2] Hop Albert Michallon, Grenoble, France
[3] Grp Hosp St Joseph, Paris, France
[4] Hop Guy, Tourcoing, France
[5] Hop Bichat Claude Bernard, F-75877 Paris 18, France
[6] Pfizer, Paris, France
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A439 / A439
页数：1
相关论文
共 50 条
  • [41] AN ECONOMIC MODEL TO COMPARE LINEZOLID, VANCOMYCIN, AND TEICOPLANIN FOR THE TREATMENT OF CONFIRMED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NOSOCOMIAL PNEUMONIA IN BRAZIL
    Niederman, M. S.
    Patel, D.
    Li, J. Z.
    Charbonneau, C.
    Ferreira, C. N.
    Figueiredo, L.
    Stephens, J. M.
    Haider, S.
    VALUE IN HEALTH, 2015, 18 (03) : A236 - A236
  • [42] Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections
    Johnson, JR
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) : 236 - 237
  • [43] COST-EFFECTIVENESS ANALYSIS OF LINEZOLID VERSUS VANCOMYCIN IN THE TREATMENT OF NOSOCOMIAL PNEUMONIA CAUSED BY METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) BASED ON A PHASE 4 CLINICAL TRIAL
    Li, J.
    Li, J. Z.
    Gao, X.
    Solem, C. T.
    Niederman, M. S.
    Chastre, J.
    Myers, D. E.
    Wan, Y.
    Stephens, J. M.
    Haider, S.
    VALUE IN HEALTH, 2013, 16 (03) : A91 - A91
  • [44] Pharmacotherapy for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Segarra-Newnham, Marisel
    Church, Timothy J.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (12) : 1678 - 1687
  • [45] Comparative Effectiveness of Linezolid and Vancomycin Among a National Veterans Affairs Cohort with Methicillin-Resistant Staphylococcus aureus Pneumonia
    Caffrey, Aisling R.
    Morrill, Haley J.
    Puzniak, Laura A.
    LaPlante, Kerry L.
    PHARMACOTHERAPY, 2014, 34 (05): : 473 - 480
  • [46] Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
    Vu, Michelle
    Smith, Kenneth J.
    Aspinall, Sherrie L.
    Clancy, Cornelius J.
    Buehrle, Deanna J.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (10) : 885 - 894
  • [47] Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
    Michelle Vu
    Kenneth J. Smith
    Sherrie L. Aspinall
    Cornelius J. Clancy
    Deanna J. Buehrle
    Clinical Drug Investigation, 2021, 41 : 885 - 894
  • [48] Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia
    Jung, Young Ju
    Koh, Younsuck
    Hong, Sang-Bum
    Chung, Joo Won
    Choi, Sang Ho
    Kim, Nam Joong
    Kim, Mi-Na
    Choi, Ik Su
    Han, Song Yi
    Kim, Won-Dong
    Yun, Sung-Cheol
    Lim, Chae-Man
    CRITICAL CARE MEDICINE, 2010, 38 (01) : 175 - 180
  • [49] Linezolid vs Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia A Meta-analysis of Randomized Controlled Trials
    Walkey, Allan J.
    O'Donnell, Max R.
    Wiener, Renda Soylemez
    CHEST, 2011, 139 (05) : 1148 - 1155
  • [50] Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus
    Kato, Hideo
    Hagihara, Mao
    Asai, Nobuhiro
    Shibata, Yuichi
    Koizumi, Yusuke
    Yamagishi, Yuka
    Mikamo, Hiroshige
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 24 : 98 - 105
12345